Join
Live feed
·
ANALYSTRatingvia Quantisnow
Alto Neuroscience Inc. logo

Chardan Capital Markets resumed coverage on Alto Neuroscience with a new price target

ByQuantisnow·Wall Street's wire, on your screen.
ANRO· Alto Neuroscience Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ANRO (Alto Neuroscience Inc.) and more on Quantisnow.